The Flu Shot Shortage^H^H^H^H^H^H^HSurplus

From USA Today — you had to know this was going to happen:

The flu-shot shortage has turned into a surplus in some areas, raising fears that some vaccine might be wasted.
Aventis Pasteur, supplier of almost all flu-shot vaccine for the USA this year, still has about 3.3 million doses to distribute to U.S. consumers. GlaxoSmithKline is on tap to ship 1.2 million shots from Europe. And MedImmune, maker of a nasal vaccine, has supplies.
But more than a dozen states contacted by USA TODAY say they have enough vaccine to meet demand. That is because many people at high risk for the flu opted to forgo shots this season, believing other people needed them more.

[Update] Astute readers will notice that after this post was up for a few hours I changed from “^K^K^K^K^K^K” to “^H^H^H^H^H^H^H”. Most people won’t care, but I was reminded by a reader that I had my edit codes messed up. That’s what I get for being cute.

Related posts:

  1. Flu Shot Frenzy
  2. Flu and the Beanie-Baby Effect
  3. A Tech Trifecta on Science Friday: Gloom, Doom & Boom
  4. Vaccines are a Lousy Business … or Not
  5. The 1% Solution & Mobile Games